RNA Symposium Attracts Thought Leaders in Basic and Translational Research to Jupiter, FL
More than 175 people attended “RNA: From Biology to Drug Discovery” at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology. It was the first major scientific conference at the institute since the pandemic began, and so researchers relished the opportunity to share recent work and reconnect. The conference attracted 18 impressive outside speakers, including multiple Howard Hughes Medical Institute investigators, members of the U.S. National Academy of Sciences and the Institute of Medicine. Incoming Max Planck President-Elect Patrick Cramer, Ph.D., shared his structural studies of the machinery underlying DNA transcription, featuring riveting imaging of transcription complexes in motion.
Wertheim UF Scripps Institute Scientists Find Potential Cellular Target for HIV Therapies
Researchers at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology have discovered a protein that appears to play a key role in helping HIV replicate in human immune cells, providing more clues about how cellular machinery allows the virus to create new copies of itself.
Genetic Cause of Als and Dementia Repaired by RNA-Targeting Strategy Developed at UF Scripps
Scientists at UF Scripps Biomedical Research have developed a potential medicine for a leading cause of ALS and dementia that works by eliminating disease-causing segments of RNA. The compound restored the health of neurons in the lab and rescued mice with the disease.
Jupiter Scientist Courtney Miller Named BioFlorida’s Entrepreneur of the Year
Praising her ongoing passion for developing a new class of treatments for cancer and addiction, Florida’s biotechnology industry organization, BioFlorida, has awarded its 2022 Weaver H. Gaines Entrepreneur of the Year award to Courtney Miller, Ph.D., director of academic affairs and a professor at UF Scripps Biomedical Research in Jupiter, Florida.
UF Innovate Honors Innovators at Fifth Standing InnOvation Celebration
More than 200 innovators and entrepreneurs gathered for UF Innovate | Tech Licensing’s fifth annual Standing InnOvation event to honor and celebrate innovators and their work at the University of Florida in fiscal year 2022.
Novel Target Discovered for Potentially Treating and Preventing Osteoarthritis
Scientists at UF Scripps Biomedical Research have described a specific protein that manages activities within chondrocytes, a critical cell type that maintains healthy cartilage in joints. As people age and stress their joints, their chondrocytes begin to fail. The UF Scripps team found that activating a specific protein in these cells called RORβ (beta) could restore multiple factors needed for smooth joints to healthier levels, helping to control inflammation.
Wertheim Foundation provides lead gift of $100 million to UF Scripps
The University of Florida today announced that the Dr. Herbert and Nicole Wertheim Family Foundation has provided $100 million — the largest gift from an individual donor in university history — to elevate the stature of UF Scripps as one of the world’s leading forces in biomedical research and to advance the leading-edge work of faculty at the campus in Jupiter, Florida.
UF Scripps Study: Opioid Drug Tolerance Develops From Interplay of Key Gene and Cholesterol
UF Scripps Biomedical Research scientists have discovered a key gene that is shedding light on how people develop tolerance to pain-relievers over time, a problem that raises risk of addiction and overdose.
Biochemist Studying How Cells Defend Against Viruses Joins UF Scripps Biomedical Research
A new scientist joining UF Scripps Biomedical Research, James M. Burke, Ph.D., is exploring how our innate immune system protects us from viruses — including the pandemic coronavirus — and how viruses evade these defenses.
Chemist Who Explores Cells’ Protein Interactions With Light To Join UF Scripps Biomedical Research
Promising new drugs sometimes fail when they reach clinical trials despite strong early data. A new scientist joining UF Scripps Biomedical Research aims to address this problem with new chemistry tools that map interactions within cells.
